Pliant Therapeutics, Inc. (PLRX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Previous Close | 0.91 |
| Open | 0.93 |
| Day High | 0.93 |
| Day Low | 0.88 |
| 52-Week High | 1.95 |
| 52-Week Low | 0.88 |
| Volume | 340,621 |
| Average Volume | 417,793 |
| Market Cap | 54.85M |
| PE | -0.61 |
| EPS | -1.46 |
| Moving Average 50 Days | 1.08 |
| Moving Average 200 Days | 1.18 |
| Change | -0.03 |
Pliant Therapeutics to Participate in the Oppenheimer Healthcare Life Science Conference
GlobeNewswire Inc.
Feb 23, 2026 1:00 PM GMT
SOUTH SAN FRANCISCO, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company focused on the discovery and development of integrin-based therapeutics, today announced its participati
Pliant Therapeutics Announces Interim Data from PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors
GlobeNewswire Inc.
Dec 04, 2025 12:30 PM GMT
One complete response and three partial responses observed in heavily pretreated ICI-secondary refractory patients in high dose cohorts Deep and durable ongoing responses with median time on treatment of 15 months Company to accelerate development o
Pliant Therapeutics to Participate in the Piper Sandler Healthcare Conference
GlobeNewswire Inc.
Dec 01, 2025 1:30 PM GMT
SOUTH SAN FRANCISCO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company focused on the discovery and development of integrin-based therapeutics, today announced its participation in th